Select Medical Q4 revenue rises 6.4%, beats estimates

Select Medical Holdings

19/02/2026 21:39

Overview

Healthcare operator's Q4 revenue rose 6.4%, beating analyst expectations

Adjusted EBITDA for Q4 decreased compared to the prior year

Company authorized $1 bln stock repurchase program

Outlook

Select Medical expects 2026 revenue between $5.6 bln and $5.8 bln

Company forecasts 2026 adjusted EBITDA between $520 mln and $540 mln

Select Medical anticipates 2026 EPS between $1.22 and $1.32

Result Drivers

REHABILITATION HOSPITALS - Revenue for the rehabilitation hospital segment increased 15.2% in Q4, driven by higher patient admissions and revenue per patient day

CRITICAL ILLNESS RECOVERY - Revenue for the critical illness recovery hospital segment rose 4.9% in Q4, supported by increased admissions and revenue per patient day

OUTPATIENT REHABILITATION - Outpatient rehabilitation segment saw a 1.6% revenue increase in Q4, but adjusted EBITDA declined significantly

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$1.40 bln
$1.36 bln (6 Analysts)
Q4 Adjusted EBITDA
$104.70 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for Select Medical Holdings Corp is $18.50, about 13.4% above its February 18 closing price of $16.32

The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nPn49HxCfa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)